Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06656624
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-23
Brief Title:
Efficacy and Safety of Ribociclib Combined With AI Versus PhysicianAmp39s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expressionHER2-negative Advanced Breast Cancer Rachel
Sponsor:
Organization:
None